Literature DB >> 14961849

Paediatric rhabdomyosarcoma of the ear and temporal bone.

D V Durve1, R G Kanegaonkar, D Albert, G Levitt.   

Abstract

The objective of the present study was to review the presentation, management, outcome and morbidity of paediatric patients presenting to a single centre with rhabdomyosarcoma of the ear and temporal region. All patients diagnosed with rhabdomyosarcoma of the ear and temporal region between 1980 and 2000 were entered into this retrospective study. Fourteen patients were identified. The median age at presentation was 4.5 years with a mean time of onset of symptoms to diagnosis of 21 weeks. In many patients, the presentation mimicked that of chronic otitis media, delaying diagnosis. Histological subtype was embryonal in 13 patients and alveolar in 1. All patients underwent multimodality treatment. The 5-year disease-free survival rate was 81%. Regional post-treatment morbidity included chronic aural discharge (6/14), facial palsy (8/14), growth disturbance (4/14) and maxillo-facial deformity occurring in four children. From the results, we conclude that these patients should usually present to an ENT surgeon who should keep the diagnosis in mind when dealing with children with chronic otitis media as early diagnosis with referral to a specialist multidisciplinary team will optimize the chance of survival. Discharge, hearing loss and aural polyp, although commonly because of chronic otitis media, should prompt urgent investigation and biopsy, particularly if associated with facial palsy, lymphadenopathy or an obvious mass.

Entities:  

Mesh:

Year:  2004        PMID: 14961849     DOI: 10.1111/j.1365-2273.2004.00764.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  10 in total

1.  A Toddler with Rhabdomyosarcoma Presenting as Acute Otitis Media with Mastoid Abscess.

Authors:  Sze Yin Ng; Bee See Goh
Journal:  Chin Med J (Engl)       Date:  2016-05-20       Impact factor: 2.628

2.  Differentiating Pediatric Rhabdomyosarcoma and Langerhans Cell Histiocytosis of the Temporal Bone by Imaging Appearance.

Authors:  K M Chevallier; R H Wiggins; N A Quinn; R K Gurgel
Journal:  AJNR Am J Neuroradiol       Date:  2016-02-11       Impact factor: 3.825

Review 3.  Petrous apex lesions in the pediatric population.

Authors:  Rupa Radhakrishnan; Hwa Jung Son; Bernadette L Koch
Journal:  Pediatr Radiol       Date:  2014-03-01

4.  Clinical and histopathological study of mass in ear: a study of fifty cases.

Authors:  Neeru M Agarwal; V C Popat; Chintan Traviad; Atul Srivastava
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-02-11

5.  A mistaken identity: rhabdomyosarcoma of the middle ear cleft misdiagnosed as chronic suppurative otitis media with temporal lobe abscess.

Authors:  Mamta Muranjan; Sunil Karande; Shefali Parikh; Shilpa Sankhe
Journal:  BMJ Case Rep       Date:  2014-09-19

6.  The sarcoma diagnostic interval: a systematic review on length, contributing factors and patient outcomes.

Authors:  Vicky Soomers; Olga Husson; Robin Young; Ingrid Desar; Winette Van der Graaf
Journal:  ESMO Open       Date:  2020-02

7.  Adult rhabdomyosarcoma originating in the temporal muscle, invading the skull and meninges: A case report.

Authors:  Geng-Huan Wang; He-Ping Shen; Zheng-Min Chu; Jian Shen
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

8.  Rhabdomyosarcoma of the middle ear cavity presenting with Horner's syndrome.

Authors:  S M Hayes; T C Biggs; J H Bird; W P Hellier
Journal:  Ann R Coll Surg Engl       Date:  2018-10-05       Impact factor: 1.951

9.  Embryonal Rhabdomyosarcoma - A Mimicker of Squamosal Otitis Media.

Authors:  Ajay Bhandarkar; Architha Menon; Ranjini Kudva; Kailesh Pujary
Journal:  Iran J Otorhinolaryngol       Date:  2020-01

10.  Management of neonatal retro-auricular embryonal rhabdomyosarcoma - Case report.

Authors:  M Jean-Christophe Roubaud; Julien Prevot; Jean-Christophe Leclere; Charlotte Mistretta; Emmanuel Mornet; Rémi Marianowski
Journal:  Int J Surg Case Rep       Date:  2020-09-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.